Need professional-grade analysis? Visit stockanalysis.com
$375.86B
48.82
20,238
0.36%
Jiangsu Hengrui Medicine Co Ltd (600276) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY54.28, up 1.19% from the previous close.
Over the past year, 600276 has traded between a low of CNY46.23 and a high of CNY72.47. The stock has gained 16.0% over this period. It is currently 26.0% below its 52-week high.
Jiangsu Hengrui Medicine Co Ltd has a market capitalization of $375.86B, with a price-to-earnings ratio of 48.82 and a dividend yield of 0.36%.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.